Fda cbd release
There's Still Only One FDA-Approved Use for CBD Oil | cannabisMD The FDA gave the makers of Epidiolex, GW Pharmaceuticals, the priority review designation reserved for drugs targeting a neglected or pediatric disease (the review voucher, which may be transferred, was later sold to another company for $105 million, which a GW press release said will be used to further its research). Before Epidiolex, no FDA FDA looking at ways to legalize sale of CBD oil in foods and On Thursday, The Food and Drug Administration (FDA) published a press release in which it said it’s currently looking for “pathways” to legalize the sale of CBD oil and other cannabis FDA Releases Warning Letters to CBD and Hemp Oil Companies | FDA asserts that the products are misbranded, unapproved new human or animal drugs.